Powered by lexis nexis

Dr. Carl H. June, Cancer Immunotherapy Pioneer, Joins CytoSorbents Scientific Advisory Board

Mar 22, 2017 - PR Newswire

CytoSorbents Corporation(NASDAQ: CTSO), a critical care immunotherapy leader commercializing its flagshipCytoSorb®blood filter to treat deadly inflammation in critically-ill and cardiac surgery patients around the world, announced that CAR T-cell cancer immunotherapy pioneer, Dr. Carl H. June, M.D., will join its scientific advisory board to help guide applications of the company's technology in the treatment of cancer.

Dr. Carl June, Director of the Center for Cellular Immunotherapies at...